HPR16 Incorporating Added Therapeutic Benefit and Domestic Reference Pricing into Medicare Payment for Expensive Part B Drugs
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1163
https://www.valueinhealthjournal.com/article/S1098-3015(23)01263-9/fulltext
Title :
HPR16 Incorporating Added Therapeutic Benefit and Domestic Reference Pricing into Medicare Payment for Expensive Part B Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01263-9&doi=10.1016/j.jval.2023.03.1163
First page :
Section Title :
Open access? :
No
Section Order :
10594